Journal ArticleViruses · December 31, 2024
Kidney transplant recipients require a lifelong protocol of immunosuppressive therapy to prevent graft rejection. However, these same medications leave them susceptible to opportunistic infections. One pathogen of particular concern is human polyomavirus 1 ...
Full textOpen AccessLink to itemCite
Journal ArticlePediatr Transplant · December 2024
BACKGROUND: Natural killer (NK) cells have gained recognition for playing an integral role in both alloimmunity and protective immunity, particularly viral infection control, in solid organ transplantation. Using data from the Clinical Trials in Organ Tran ...
Full textLink to itemCite
Journal ArticleNat Commun · August 10, 2024
Therapeutic apheresis aims to selectively remove pathogenic substances, such as antibodies that trigger various symptoms and diseases. Unfortunately, current apheresis devices cannot handle small blood volumes in infants or small animals, hindering the tes ...
Full textOpen AccessLink to itemCite
Journal ArticlePediatr Nephrol · July 2024
BACKGROUND: An accurate, rapid estimate of glomerular filtration rate (GFR) in kidney transplant patients affords early detection of transplant deterioration and timely intervention. This study compared the performance of serum creatinine (Cr) and cystatin ...
Full textLink to itemCite
Journal ArticleTransplantation · January 1, 2024
BACKGROUND: Angiotensin II type 1 receptor antibodies (AT1R-Abs) and endothelin-type A receptor antibodies (ETAR-Abs) are G protein-coupled receptor activating autoantibodies associated with antibody-mediated rejection, vascular pathology, increased cytoki ...
Full textLink to itemCite
Journal ArticleMicrosyst Nanoeng · 2024
Separating plasma from whole blood is an important sample processing technique required for fundamental biomedical research, medical diagnostics, and therapeutic applications. Traditional protocols for plasma isolation require multiple centrifugation steps ...
Full textOpen AccessLink to itemCite
Journal ArticleTransplantation · November 1, 2023
Posttransplant lymphoproliferative disorder (PTLD) represents a heterogeneous group of lymphoproliferative diseases occurring in the setting of immunosuppression following hematopoietic stem cells transplant and solid organ transplantation. Despite its ove ...
Full textLink to itemCite
Journal ArticleCureus · November 2023
Acute and chronic kidney disease (CKD) have known neurological associations resulting from uremia, electrolyte disturbances, comorbidities such as hypertension, or other toxin accumulation. Reversible focal neurological deficits are relatively uncommon and ...
Full textLink to itemCite
Journal ArticleTransplant Direct · April 2023
UNLABELLED: Kidney transplant (KT) recipients who are not actively engaged in their care and lack self-management skills have poor transplant outcomes, which are disproportionately observed among Black KT recipients. This pilot study aimed to determine whe ...
Full textLink to itemCite
Journal ArticleFront Nephrol · 2023
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease requiring kidney transplantation and can recur in the allograft in 30-80% of recipients resulting in reduced graft survival. Plasmapheresis has shown effica ...
Full textLink to itemCite
Journal ArticleFront Pediatr · 2023
INTRODUCTION: The etiology of most cases of nephrotic syndrome (NS) remains unknown, therefore patients are phenotypically categorized based on response to corticosteroid therapy as steroid sensitive NS (SSNS), or steroid resistant NS (SRNS). Genetic risk ...
Full textLink to itemCite
Journal ArticlePediatr Transplant · December 2022
BACKGROUND: Malnutrition, including obesity and undernutrition, among children is increasing in prevalence and is common among children on renal replacement therapy. The effect of malnutrition on the pre-transplant immune system and how the pediatric immun ...
Full textLink to itemCite
ConferenceClin Transplant · August 2022
BACKGROUND: Treatment options for antibody-mediated rejection (AMR) are limited. Recent studies have shown that inhibition of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling can reduce inflammation and slow AMR progression. METHODS: We report ...
Full textLink to itemCite
Journal ArticleTransplant Direct · March 2022
UNLABELLED: With the rapid and widespread expansion of smartphone availability and usage, mobile health (mHealth) has become a viable multipurpose treatment medium for the US healthcare system. METHODS: The purpose of this review is to identify posttranspl ...
Full textLink to itemCite
Journal ArticlePLoS One · 2022
BACKGROUND: Pediatric solid organ transplant (SOT) recipients commonly have Epstein-Barr virus (EBV) DNAemia and are at risk of developing post-transplant lymphoproliferative disorder (PTLD). EBV DNAemia has not been analyzed on a continuous scale in this ...
Full textLink to itemCite
Journal ArticleTransplantation · December 1, 2021
BACKGROUND: Immunological mechanisms linking undernutrition to infection and the alloimmune response are poorly understood in transplantation. We aimed to determine how undernutrition and hypoleptinemia impact T-cell allospecific and cytomegalovirus (CMV) ...
Full textLink to itemCite
Journal ArticleTransplant Direct · October 2021
UNLABELLED: Recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplantation accounts for the majority of allograft failures in children with primary FSGS. Although current research focuses on FSGS pathophysiology, a common etiology and mec ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Transplant · February 2021
Depletional induction using antithymocyte globulin (ATG) reduces rates of acute rejection in adult kidney transplant recipients, yet little is known about its effects in children. Using a longitudinal cohort of 103 patients in the Immune Development in Ped ...
Full textLink to itemCite
Journal ArticleKidney Int Rep · November 2020
INTRODUCTION: Autoantibody to angiotensin II type 1 receptor (AT1R-Ab) has been recognized as a non-human leukocyte antigen (HLA) antibody relevant in transplantation. Endothelin type A receptor antibody (ETAR-Ab) has been strongly associated with AT1R-Ab, ...
Full textLink to itemCite
Journal ArticleAm J Transplant · March 2020
Adolescent transplant recipients are at risk for nonadherence, development of de novo donor-specific antibody (dnDSA), and allograft loss. Belatacept, a selective T cell costimulatory blocker, is associated with reduced dnDSA, improved renal function, and ...
Full textLink to itemCite
Journal ArticleTheranostics · 2020
Acute rejection (AR) remains a significant problem that negatively impacts long-term renal allograft survival. Numerous therapies are used to prevent AR that differ by center and recipient age. This variability confounds diagnostic methods. Methods: To dev ...
Full textOpen AccessLink to itemCite
Journal ArticleKidney Int · October 2019
Although the pathogenesis of steroid-sensitive nephrotic syndrome (SSNS) remains elusive, multiple epidemiologic, clinical, and experimental studies converge on the common theme of immune dysregulation. Initially, T-cell adaptive immunity was solely emphas ...
Full textLink to itemCite
Journal ArticleKidney Int Rep · April 2019
INTRODUCTION: Angiotensin II type 1 receptor antibody (AT1R-Ab), is a non-human leukocyte antigen (HLA) antibody implicated in poor renal allograft outcomes, although its actions may be mediated through a different pathway than HLA donor-specific antibodie ...
Full textLink to itemCite
Journal ArticlePediatr Nephrol · March 2019
The original version of this article unfortunately contained a mistake. The subtitle "A Midwest Pediatric Nephrology Consortium (MWPNC) study" was missing. The correct title including subtitle is given above. ...
Full textLink to itemCite
Journal ArticleFront Pediatr · 2019
Background: Currently, there is no standardized approach for determining psychosocial readiness in pediatric transplantation. We examined the utility of the Psychosocial Assessment of Candidates for Transplantation (PACT) to identify pediatric kidney trans ...
Full textOpen AccessLink to itemCite
Chapter · January 1, 2019
Solid organ transplantation remains a limited resource despite an increasing number of patients who require this life saving procedure. Understanding the unique intersection between donor and recipient genomes lies at the core of precision medicine in tran ...
Full textCite
Journal ArticlePediatr Nephrol · October 2018
BACKGROUND AND OBJECTIVES: Steroid-resistant nephrotic syndrome (SRNS) due to focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is a leading cause of end-stage kidney disease in children. Recurrence of primary disease following tra ...
Full textLink to itemCite
Journal ArticleKidney Int · January 2018
Angiotensin II type 1 receptor (AT1R) antibody has been linked to poor allograft outcomes in adult kidney transplantation. However, its clinical consequences in children are unknown. To study this, we examined the relationship of AT1R antibody with clinica ...
Full textLink to itemCite
Journal ArticlePediatr Transplant · November 2017
Pediatric sHKTx has become an effective therapy for patients with combined cardiac and renal failure. Often, these patients develop human leukocyte antigen antibodies from their previous allografts and are therefore more difficult to re-transplant. We desc ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2017
The Immune Development in Pediatric Transplantation (IMPACT) study was conducted to evaluate relationships among alloimmunity, protective immunity, immune development, physical parameters, and clinical outcome in children undergoing kidney transplantation. ...
Full textLink to itemCite
Journal ArticleClin Transpl · 2016
Antibody-mediated rejection in solid organ transplantation is associated with significant organ dysfunction and allograft loss. Donor-specific antibodies against human leukocyte antigens (HLAs) have been a major focus for research, clinical testing, and th ...
Link to itemCite